Colgate-Palmolive Reports Progress on Restructuring Program as Charges Reach $318 Million
The consumer products giant has incurred cumulative pre-tax charges of $318 million under its Strategic Growth and Productivity Program, with total costs expected to reach up to $550 million by 2028.
Restructuring Program Intensifies
Colgate-Palmolive Company disclosed cumulative pre-tax charges of $318 million ($253 million after-tax) related to its Strategic Growth and Productivity Program, according to its quarterly filing with the Securities and Exchange Commission (10-Q filing, 2026-07-31). The three-year initiative, initially approved by the Board of Directors on July 31, 2025, aims to realign the company's organizational structure and optimize its global supply chain to support its 2030 strategic goals.
The program was expanded on April 30, 2026, with total pre-tax charges now estimated to range between $350 million and $550 million once all initiatives are implemented. The company expects substantially all charges to be incurred by December 31, 2028, with approximately 80% to 90% resulting in cash expenditures (10-Q filing, 2026-07-31).
Charge Composition and Geographic Distribution
The restructuring costs are primarily employee-related, with severance and termination benefits comprising an estimated 70% to 80% of total charges. Asset-related costs and other charges, including accelerated depreciation and contract terminations, account for the remaining 20% to 30% (10-Q filing, 2026-07-31).
Geographically, the largest portion of charges is expected to impact the EMEA region at 25% to 30%, followed by Latin America at 15% to 20%. Corporate functions are projected to absorb 20% to 25% of total costs, while North America, Asia Pacific, and Hill's Pet Nutrition segments each represent smaller proportions (10-Q filing, 2026-07-31).
Segment Realignment
Effective for the quarter ended March 31, 2026, Colgate-Palmolive reorganized its reportable operating segments to optimize scale within Europe and Africa. The company combined its Europe and Africa/Eurasia segments (excluding Russia and Belarus) with its skin health business into a new EMEA reportable operating segment. Concurrently, Russia and Belarus operations were transferred to the Asia Pacific segment (10-Q filing, 2026-07-31).
This realignment resulted in the reallocation of approximately $19 million in goodwill from the EMEA segment to the Asia Pacific segment. The company completed an assessment confirming no goodwill impairment existed as a result of the new reporting structure (10-Q filing, 2026-07-31).
Capital Allocation Activity
The company continues to execute share repurchases under its $5 billion program authorized on March 20, 2025, which replaced a previous authorization. The 2025 Program allows for open market or privately negotiated transactions at the company's discretion, subject to market conditions and customary blackout periods (10-Q filing, 2026-07-31).
Additionally, Colgate-Palmolive acquired Care TopCo Pty Ltd, owner of the Prime100 pet food business in Australia, on April 30, 2025, for AU $471 million ($301 million). The acquisition, which provides entry into the fast-growing fresh pet food category, generated $207 million in goodwill allocated to the Hill's Pet Nutrition segment. The company finalized its purchase price allocation during the second quarter of 2026 (10-Q filing, 2026-07-31).
Risk Factors and Legal Matters
The filing noted no material changes from risk factors disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2025. For legal matters, including ERISA litigation, the company referenced Note 10 of its Condensed Consolidated Financial Statements (10-Q filing, 2026-07-31).
According to MarginX data, recent insider activity included award grants to directors Brian Newman (209 shares), Lorrie M. Norrington (293 shares), and John P. Bilbrey (265 shares).
This article was generated by MarginX from the 10-Q filing on 2026-07-31. It is not investment advice.